+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Respiratory Drugs Market 2024-2028

  • PDF Icon

    Report

  • 179 Pages
  • September 2024
  • Region: Global
  • TechNavio
  • ID: 5576351
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The respiratory drugs market is forecasted to grow by USD 30.8 billion during 2023-2028, accelerating at a CAGR of 6.19% during the forecast period. The report on the respiratory drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by need for sustainable and safe respiratory drugs, rising prevalence of respiratory diseases, and increasing tobacco consumption.

The respiratory drugs market is segmented as below:

By Type

  • Asthma
  • COPD
  • Allergic rhinitis
  • Cystic fibrosis
  • Other respiratory diseases

By Distribution Channel

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the emergence of telehealth and remote monitoring as one of the prime reasons driving the respiratory drugs market growth during the next few years. Also, adoption of biologics and targeted therapies and rising digital health integration will lead to sizable demand in the market.

The report on the respiratory drugs market covers the following areas:

  • Respiratory drugs market sizing
  • Respiratory drugs market forecast
  • Respiratory drugs market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading respiratory drugs market vendors that include Abbott Laboratories, AbbVie Inc., Aerogen Pharma Ltd., AstraZeneca Plc, Aurobindo Pharma Ltd., Boehringer Ingelheim International GmbH, Celon Pharma SA, Cipla Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Laboratory Corp. of America Holdings, Lupin Ltd., Medisol Lifescience Pvt. Ltd., Merck and Co. Inc., Novartis AG, Sumitomo Pharma Co. Ltd., Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Inc., and Wellona Pharma. Also, the respiratory drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
2.2 Market characteristics
  • Market characteristics analysis
2.3 Value chain analysis
  • Value Chain Analysis
3 Market Sizing
3.1 Market definition
  • Offerings of companies included in the market definition
3.2 Market segment analysis
  • Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Respiratory Drugs Market 2018 - 2022
  • Historic Market Size - Data Table on Global Respiratory Drugs Market 2018 - 2022 ($ billion)
4.2 Type segment analysis 2018 - 2022
  • Historic Market Size - Type Segment 2018 - 2022 ($ billion)
4.3 Distribution Channel segment analysis 2018 - 2022
  • Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
4.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
6.1 Market segments
  • Chart on Type - Market share 2023-2028 (%)
  • Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
6.3 Asthma - Market size and forecast 2023-2028
  • Chart on Asthma - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Asthma - Market size and forecast 2023-2028 ($ billion)
  • Chart on Asthma - Year-over-year growth 2023-2028 (%)
  • Data Table on Asthma - Year-over-year growth 2023-2028 (%)
6.4 COPD - Market size and forecast 2023-2028
  • Chart on COPD - Market size and forecast 2023-2028 ($ billion)
  • Data Table on COPD - Market size and forecast 2023-2028 ($ billion)
  • Chart on COPD - Year-over-year growth 2023-2028 (%)
  • Data Table on COPD - Year-over-year growth 2023-2028 (%)
6.5 Allergic rhinitis - Market size and forecast 2023-2028
  • Chart on Allergic rhinitis - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Allergic rhinitis - Market size and forecast 2023-2028 ($ billion)
  • Chart on Allergic rhinitis - Year-over-year growth 2023-2028 (%)
  • Data Table on Allergic rhinitis - Year-over-year growth 2023-2028 (%)
6.6 Cystic fibrosis - Market size and forecast 2023-2028
  • Chart on Cystic fibrosis - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Cystic fibrosis - Market size and forecast 2023-2028 ($ billion)
  • Chart on Cystic fibrosis - Year-over-year growth 2023-2028 (%)
  • Data Table on Cystic fibrosis - Year-over-year growth 2023-2028 (%)
6.7 Other respiratory diseases - Market size and forecast 2023-2028
  • Chart on Other respiratory diseases - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Other respiratory diseases - Market size and forecast 2023-2028 ($ billion)
  • Chart on Other respiratory diseases - Year-over-year growth 2023-2028 (%)
  • Data Table on Other respiratory diseases - Year-over-year growth 2023-2028 (%)
6.8 Market opportunity by Type
  • Market opportunity by Type ($ billion)
  • Data Table on Market opportunity by Type ($ billion)
7 Market Segmentation by Distribution Channel
7.1 Market segments
  • Chart on Distribution Channel - Market share 2023-2028 (%)
  • Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
  • Chart on Comparison by Distribution Channel
  • Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacies - Market size and forecast 2023-2028
  • Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
  • Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
  • Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
7.4 Retail pharmacies - Market size and forecast 2023-2028
  • Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
  • Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
  • Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
7.5 Online pharmacies - Market size and forecast 2023-2028
  • Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
  • Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
  • Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ billion)
  • Data Table on Market opportunity by Distribution Channel ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ billion)
  • Data Table on China - Market size and forecast 2023-2028 ($ billion)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ billion)
  • Data Table on UK - Market size and forecast 2023-2028 ($ billion)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ billion)
  • Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
  • Overview on factors of disruption
11.4 Industry risks
  • Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
  • Companies covered
12.2 Market positioning of companies
  • Matrix on companies position and classification
12.3 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
12.4 AbbVie Inc.
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Product / Service
  • AbbVie Inc. - Key news
  • AbbVie Inc. - Key offerings
12.5 Aerogen Pharma Ltd.
  • Aerogen Pharma Ltd. - Overview
  • Aerogen Pharma Ltd. - Product / Service
  • Aerogen Pharma Ltd. - Key offerings
12.6 AstraZeneca Plc
  • AstraZeneca Plc - Overview
  • AstraZeneca Plc - Product / Service
  • AstraZeneca Plc - Key news
  • AstraZeneca Plc - Key offerings
12.7 Boehringer Ingelheim International GmbH
  • Boehringer Ingelheim International GmbH - Overview
  • Boehringer Ingelheim International GmbH - Product / Service
  • Boehringer Ingelheim International GmbH - Key news
  • Boehringer Ingelheim International GmbH - Key offerings
12.8 Celon Pharma SA
  • Celon Pharma SA - Overview
  • Celon Pharma SA - Product / Service
  • Celon Pharma SA - Key offerings
12.9 Cipla Inc.
  • Cipla Inc. - Overview
  • Cipla Inc. - Business segments
  • Cipla Inc. - Key news
  • Cipla Inc. - Key offerings
  • Cipla Inc. - Segment focus
12.10 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
12.11 GlaxoSmithKline Plc
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key news
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Segment focus
12.12 Glenmark Pharmaceuticals Ltd.
  • Glenmark Pharmaceuticals Ltd. - Overview
  • Glenmark Pharmaceuticals Ltd. - Product / Service
  • Glenmark Pharmaceuticals Ltd. - Key offerings
12.13 Lupin Ltd.
  • Lupin Ltd. - Overview
  • Lupin Ltd. - Business segments
  • Lupin Ltd. - Key news
  • Lupin Ltd. - Key offerings
  • Lupin Ltd. - Segment focus
12.14 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus
12.15 Sumitomo Pharma Co. Ltd.
  • Sumitomo Pharma Co. Ltd. - Overview
  • Sumitomo Pharma Co. Ltd. - Business segments
  • Sumitomo Pharma Co. Ltd. - Key offerings
  • Sumitomo Pharma Co. Ltd. - Segment focus
12.16 Teva Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd. - Overview
  • Teva Pharmaceutical Industries Ltd. - Business segments
  • Teva Pharmaceutical Industries Ltd. - Key news
  • Teva Pharmaceutical Industries Ltd. - Key offerings
  • Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Vertex Pharmaceuticals Inc.
  • Vertex Pharmaceuticals Inc. - Overview
  • Vertex Pharmaceuticals Inc. - Product / Service
  • Vertex Pharmaceuticals Inc. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
13.4 Research methodology
  • Research methodology
13.5 Data procurement
  • Information sources
13.6 Data validation
  • Data validation
13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
13.8 Data synthesis
  • Data synthesis
13.9 360 degree market analysis
  • 360 degree market analysis
13.10 List of abbreviations
  • List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 17: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 20: Historic Market Size - Data Table on Global Respiratory Drugs Market 2018 - 2022 ($ billion)
Exhibits 21: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits 22: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
Exhibits 23: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits 24: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits 25: Five forces analysis - Comparison between 2023 and 2028
Exhibits 26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 31: Chart on Market condition - Five forces 2023 and 2028
Exhibits 32: Chart on Type - Market share 2023-2028 (%)
Exhibits 33: Data Table on Type - Market share 2023-2028 (%)
Exhibits 34: Chart on Comparison by Type
Exhibits 35: Data Table on Comparison by Type
Exhibits 36: Chart on Asthma - Market size and forecast 2023-2028 ($ billion)
Exhibits 37: Data Table on Asthma - Market size and forecast 2023-2028 ($ billion)
Exhibits 38: Chart on Asthma - Year-over-year growth 2023-2028 (%)
Exhibits 39: Data Table on Asthma - Year-over-year growth 2023-2028 (%)
Exhibits 40: Chart on COPD - Market size and forecast 2023-2028 ($ billion)
Exhibits 41: Data Table on COPD - Market size and forecast 2023-2028 ($ billion)
Exhibits 42: Chart on COPD - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on COPD - Year-over-year growth 2023-2028 (%)
Exhibits 44: Chart on Allergic rhinitis - Market size and forecast 2023-2028 ($ billion)
Exhibits 45: Data Table on Allergic rhinitis - Market size and forecast 2023-2028 ($ billion)
Exhibits 46: Chart on Allergic rhinitis - Year-over-year growth 2023-2028 (%)
Exhibits 47: Data Table on Allergic rhinitis - Year-over-year growth 2023-2028 (%)
Exhibits 48: Chart on Cystic fibrosis - Market size and forecast 2023-2028 ($ billion)
Exhibits 49: Data Table on Cystic fibrosis - Market size and forecast 2023-2028 ($ billion)
Exhibits 50: Chart on Cystic fibrosis - Year-over-year growth 2023-2028 (%)
Exhibits 51: Data Table on Cystic fibrosis - Year-over-year growth 2023-2028 (%)
Exhibits 52: Chart on Other respiratory diseases - Market size and forecast 2023-2028 ($ billion)
Exhibits 53: Data Table on Other respiratory diseases - Market size and forecast 2023-2028 ($ billion)
Exhibits 54: Chart on Other respiratory diseases - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Other respiratory diseases - Year-over-year growth 2023-2028 (%)
Exhibits 56: Market opportunity by Type ($ billion)
Exhibits 57: Data Table on Market opportunity by Type ($ billion)
Exhibits 58: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits 59: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits 60: Chart on Comparison by Distribution Channel
Exhibits 61: Data Table on Comparison by Distribution Channel
Exhibits 62: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits 63: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits 64: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 65: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 66: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits 67: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits 68: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 69: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 70: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits 71: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits 72: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 73: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 74: Market opportunity by Distribution Channel ($ billion)
Exhibits 75: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits 76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 77: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 78: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 79: Chart on Geographic comparison
Exhibits 80: Data Table on Geographic comparison
Exhibits 81: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 82: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 83: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 86: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 87: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 90: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 91: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 94: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 95: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 98: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 99: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 101: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 102: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 103: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 104: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 105: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits 106: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits 107: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 108: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 109: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 110: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 111: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 112: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 113: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 114: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 115: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 116: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 117: Market opportunity By Geographical Landscape ($ billion)
Exhibits 118: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 119: Impact of drivers and challenges in 2023 and 2028
Exhibits 120: Overview on criticality of inputs and factors of differentiation
Exhibits 121: Overview on factors of disruption
Exhibits 122: Impact of key risks on business
Exhibits 123: Companies covered
Exhibits 124: Matrix on companies position and classification
Exhibits 125: Abbott Laboratories - Overview
Exhibits 126: Abbott Laboratories - Business segments
Exhibits 127: Abbott Laboratories - Key news
Exhibits 128: Abbott Laboratories - Key offerings
Exhibits 129: Abbott Laboratories - Segment focus
Exhibits 130: AbbVie Inc. - Overview
Exhibits 131: AbbVie Inc. - Product / Service
Exhibits 132: AbbVie Inc. - Key news
Exhibits 133: AbbVie Inc. - Key offerings
Exhibits 134: Aerogen Pharma Ltd. - Overview
Exhibits 135: Aerogen Pharma Ltd. - Product / Service
Exhibits 136: Aerogen Pharma Ltd. - Key offerings
Exhibits 137: AstraZeneca Plc - Overview
Exhibits 138: AstraZeneca Plc - Product / Service
Exhibits 139: AstraZeneca Plc - Key news
Exhibits 140: AstraZeneca Plc - Key offerings
Exhibits 141: Boehringer Ingelheim International GmbH - Overview
Exhibits 142: Boehringer Ingelheim International GmbH - Product / Service
Exhibits 143: Boehringer Ingelheim International GmbH - Key news
Exhibits 144: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 145: Celon Pharma SA - Overview
Exhibits 146: Celon Pharma SA - Product / Service
Exhibits 147: Celon Pharma SA - Key offerings
Exhibits 148: Cipla Inc. - Overview
Exhibits 149: Cipla Inc. - Business segments
Exhibits 150: Cipla Inc. - Key news
Exhibits 151: Cipla Inc. - Key offerings
Exhibits 152: Cipla Inc. - Segment focus
Exhibits 153: F. Hoffmann La Roche Ltd. - Overview
Exhibits 154: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 155: F. Hoffmann La Roche Ltd. - Key news
Exhibits 156: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 157: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 158: GlaxoSmithKline Plc - Overview
Exhibits 159: GlaxoSmithKline Plc - Business segments
Exhibits 160: GlaxoSmithKline Plc - Key news
Exhibits 161: GlaxoSmithKline Plc - Key offerings
Exhibits 162: GlaxoSmithKline Plc - Segment focus
Exhibits 163: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits 164: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits 165: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits 166: Lupin Ltd. - Overview
Exhibits 167: Lupin Ltd. - Business segments
Exhibits 168: Lupin Ltd. - Key news
Exhibits 169: Lupin Ltd. - Key offerings
Exhibits 170: Lupin Ltd. - Segment focus
Exhibits 171: Novartis AG - Overview
Exhibits 172: Novartis AG - Business segments
Exhibits 173: Novartis AG - Key news
Exhibits 174: Novartis AG - Key offerings
Exhibits 175: Novartis AG - Segment focus
Exhibits 176: Sumitomo Pharma Co. Ltd. - Overview
Exhibits 177: Sumitomo Pharma Co. Ltd. - Business segments
Exhibits 178: Sumitomo Pharma Co. Ltd. - Key offerings
Exhibits 179: Sumitomo Pharma Co. Ltd. - Segment focus
Exhibits 180: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 181: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 182: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 183: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 184: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 185: Vertex Pharmaceuticals Inc. - Overview
Exhibits 186: Vertex Pharmaceuticals Inc. - Product / Service
Exhibits 187: Vertex Pharmaceuticals Inc. - Key offerings
Exhibits 188: Inclusions checklist
Exhibits 189: Exclusions checklist
Exhibits 190: Currency conversion rates for US$
Exhibits 191: Research methodology
Exhibits 192: Information sources
Exhibits 193: Data validation
Exhibits 194: Validation techniques employed for market sizing
Exhibits 195: Data synthesis
Exhibits 196: 360 degree market analysis
Exhibits 197: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global respiratory drugs market: Abbott Laboratories, AbbVie Inc., Aerogen Pharma Ltd., AstraZeneca Plc, Aurobindo Pharma Ltd., Boehringer Ingelheim International GmbH, Celon Pharma SA, Cipla Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Laboratory Corp. of America Holdings, Lupin Ltd., Medisol Lifescience Pvt. Ltd., Merck and Co. Inc., Novartis AG, Sumitomo Pharma Co. Ltd., Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Inc., and Wellona Pharma.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is emergence of telehealth and remote monitoring."

According to the report, one of the major drivers for this market is the need for sustainable and safe respiratory drugs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • AbbVie Inc.
  • Aerogen Pharma Ltd.
  • AstraZeneca Plc
  • Aurobindo Pharma Ltd.
  • Boehringer Ingelheim International GmbH
  • Celon Pharma SA
  • Cipla Inc.
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • Glenmark Pharmaceuticals Ltd.
  • Laboratory Corp. of America Holdings
  • Lupin Ltd.
  • Medisol Lifescience Pvt. Ltd.
  • Merck and Co. Inc.
  • Novartis AG
  • Sumitomo Pharma Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Vertex Pharmaceuticals Inc.
  • Wellona Pharma